The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells

被引:67
作者
Endl, E
Kausch, I
Baack, M
Knippers, R
Gerdes, J
Scholzen, T
机构
[1] Res Ctr Borstel, Div Mol Immunol, Dept Immunol & Cell Biol, D-23845 Borstel, Germany
[2] Univ Konstanz, Div Biol, D-78434 Constance, Germany
关键词
proliferation marker; Ki-67; MCM3; p27;
D O I
10.1002/path.978
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mini-chromosome maintenance proteins (MCM), which are involved in the control of DNA replication, and the cyclin-dependent kinase inhibitors, such as p27/KIP1, represent two groups of proteins that are currently under investigation as diagnostic tumour markers. The expression of p27 and MCM3 was compared with: the expression of the Ki-67 protein, an approved marker for proliferating cells, extensively used in histopathology and cancer research. The expression pattern of all three proteins was assessed on germinal centres and oral mucosa, which display a well-defined spatio-temporal organization. The expression of the p27 protein was closely related to differentiated cells, whereas MCM3 and Ki-67 were predominantly localized to the regions of proliferating cells. However, it is important to note that considerable numbers of cells that were growth-arrested, as confirmed by the absence of the Ki-67 protein, stained positive for the MCM3 protein. These results were verified in vitro using growth-arrested Swiss 3T3. The MCM3 protein is therefore expressed in cells that have ceased to proliferate, but are not terminally differentiated, according to the absence of p27 protein expression. In conclusion, a combined analysis of Ki-67, MCM3, and p27 protein expression may provide a more detailed insight into the cell proliferation and differentiation processes that determine individual tumour growth. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 34 条
  • [1] SIMULTANEOUS STAINING OF EXPONENTIALLY GROWING VERSUS PLATEAU PHASE CELLS WITH THE PROLIFERATION-ASSOCIATED ANTIBODY KI-67 AND PROPIDIUM IODIDE - ANALYSIS BY FLOW-CYTOMETRY
    BAISCH, H
    GERDES, J
    [J]. CELL AND TISSUE KINETICS, 1987, 20 (04): : 387 - 391
  • [2] BRONS PPT, 1992, BLOOD, V80, P2336
  • [3] BURKHART R, 1995, EUR J BIOCHEM, V228, P431
  • [4] Chang J, 2000, CANCER-AM CANCER SOC, V89, P2145, DOI 10.1002/1097-0142(20001201)89:11<2145::AID-CNCR1>3.0.CO
  • [5] 2-S
  • [6] FUJITA M, 1999, FRONT BIOSCI, V4, P816
  • [7] IMMUNOHISTOLOGICAL DETECTION OF TUMOR-GROWTH FRACTION (KI-67 ANTIGEN) IN FORMALIN-FIXED AND ROUTINELY PROCESSED TISSUES
    GERDES, J
    BECKER, MHG
    KEY, G
    CATTORETTI, G
    [J]. JOURNAL OF PATHOLOGY, 1992, 168 (01) : 85 - 86
  • [8] Gerdes J, 1984, Hematol Oncol, V2, P365
  • [9] PRODUCTION OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH A HUMAN NUCLEAR ANTIGEN ASSOCIATED WITH CELL-PROLIFERATION
    GERDES, J
    SCHWAB, U
    LEMKE, H
    STEIN, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (01) : 13 - 20
  • [10] The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer
    Goodson, WH
    Moore, DH
    Ljung, BM
    Chew, K
    Florendo, C
    Mayall, B
    Smith, HS
    Waldman, FM
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (02) : 155 - 164